The PennZone

  • Home
  • Non-profit
  • Technology
  • Education
  • Construction
  • Business
  • Entertainment
  • Health
  • Software

Introducing the Live Active Five: Now Available in the U.S
The PennZone/10039721

Trending...
  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan
  • Tennessee Laws Lead with Psychotropic Drug Testing in Mass Shooting Cases and Comprehensive Reporting: CCHR Urges Nationwide Adoption
  • Thou Shalt not Commit Adultery Lifetime Movie Discussion
ALLENTOWN, Pa. - PennZone -- The Live Active Five portable oxygen concentrator (POC) from Precision Medical is now available from your durable medical equipment (DME) provider. The Live Active Five is designed to help people with respiratory diseases such as COPD gain greater freedom, so they can live actively with oxygen therapy.

Precision Medical is the only POC manufacturer that utilizes Vacuum Pressure Swing Adsorption (VPSA) technology ensuring each sieve bed is perfectly regenerated every cycle. The Live Active Five weighs only 5 lbs and delivers up to 95.5% oxygen purity.  With more than 6 hours of duration with each battery, the Live Active Five has been engineered to help users go anywhere as long as they like. With its innovative ergonomic design, the dual-curved Live Active Five can be worn on either side or cross body giving users hands free comfort. The five (5) pulse flow settings and intuitive display screen makes the Live Active Five the easiest POC to use with just the touch of a button. Giving users added peace of mind, the Live Active Five's bright LCD screen and large numbers precisely display remaining battery duration in both percentage as well as hours and minutes.

More on The PennZone
  • Community, Conservation & Waterwise Inspiration Bloom on June 6
  • Industrial and systems engineers celebrate key leaders in the field at IISE Annual Conference
  • Cosanostra Miami Rises as the Best Latin Nightclub in Miami in Under Two Years From its Opening
  • CCHR Leader's 50-Year Fight for Psychiatric Drug Victims Gains National Momentum
  • Endless Mountain Music Festival Celebrates 21st Season with America250-Inspired Lineup

The Live Active Five is simple to operate and comes with a powerful lithium-ion battery, AC wall charger and DC car charger, comfortable carry bag, and a three-year device warranty. Mike Krupa, CEO of Precision Medical, said "We've engineered the Live Active Five with a sieve bed assembly that is field replaceable using a standard screwdriver, avoiding the need to return the device to a service center or back to the manufacturer, which in turn reduces the cost of ownership for our DME partners. Our team also tested many battery designs to understand what's easiest for users. Based on feedback and testing, we designed a top loading battery that is changed in seconds to a newly charged battery. And we're still the only POC manufacturer utilizing VPSA technology. This fundamental technology benefits our oxygen users by delivering the highest oxygen purity possible from a POC."

The all new Live Active Five represents a major investment in high-quality innovative products from Precision Medical. Since 1982, Precision Medical has been a leader in respiratory care devices and the company continues to manufacture hospital, homecare and medical fittings products in the United States.

  For more information, visit us www.precisionmedical.com

Source: Precision Medical

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Creative Investment Research Analysis Finds Slower GDP Growth, Rising Inflation
  • TechHouse Earns Highly Selective Microsoft Support Badge
  • J&J Exterminating Celebrates 65th Anniversary and Unveils Strategic Vision at Annual Team Meeting
  • Tru by Hilton El Paso Airport Opens to Guests
  • Zenylitics Announces Leadership Transition to Continue Accelerated Growth
  • Wellness Technology Distributor Helping People Set Up Wellness Center Businesses
  • Christian Apocalyptic Thriller Explores Biblical Prophecy, Global Technology, & the Rise of the Ant
  • Turnstone Creative Expands Leadership Team with Addition of Marketing Manager
  • The Hidden Price Of Lost Property In UK Schools
  • Milton Collier, CEO & President of Freight Broker 911, Eliminates the #1 Barrier to Entry in Logistics: Announces 100% Free Freight Broker Training
  • FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
  • AI Velocity Trading Launches Institutional-Grade Algorithmic Engine for Retail Investors
  • Calvetta Phair, CEO America's Workforce Solution, LLC Assessed "Awardable" for Department of War work in the CDAO's Tradewinds Solutions Marketplace
  • Speaker and Certified Coach Syrena N. Williams Debuts Powerful New Book on Healing, Identity, and Wholeness
  • Lord of the Rings, Doctor Who' Q&As, Local Sessions Highlight FAN EXPO Philadelphia Programming
  • Kryptokasinot.io Raises Concerns Over Proposed Cryptocurrency Restrictions in Finland's Gambling Reform
  • New Home of the Month: Spacious Luxury Meets Modern Design in The Bristol at Heritage at Manalapan
  • The Calida Group Announces Sale of Ely at Fort Apache for $57.5 Million
  • Tina Hasselbusch, co-founder and CEO of Turnstone Creative, Receives Circle of Excellence from Lehigh Valley Business
  • Summer Festivals in Gunma Prefecture: Song, Dance, and Vibrant Color – Get There Via Tobu Railway!

Popular on PennZone

  • People & Stories/Gente y Cuentos Welcomes Two New Trustees as Organization Enters 54th Year and Expands Community Reach
  • Assymetrix Launches the Deepest Independent Prediction Market Data API
  • Resident Inspect Joins Property Meld Nexus Network with API Integration
  • RAS AP Consulting Advances to RFP Stage in Heidelberg Materials' SAP Vendor & Customer Master Data Modernization Initiative
  • Expert E-Bike Safety Advocate Issues Urgent Warning Following Recent Southern California Fatalities
  • CCHR: 'Plant-Based' Psychedelics Push Masks Synthetic Drugs and Billion-Dollar Profits
  • "I'm Sicka Church Too: Give Me Kingdom!" Ignites a Powerful Call for Healing and Truth
  • Umbrella Becomes First FinOps Platform to Support AWS Billing Transfer Onboarding
  • Veikkaus Appoints New CFO as Finland's Gambling Monopoly Braces for Breakup
  • BTR: i2 Group Launches i2 Amplify, a Community Platform for Intelligence Professionals Worldwide

Similar on PennZone

  • Lineus Medical Completes Financial Restructuring with KMF Investments- Launching a New Era for SafeBreak
  • Neuro Recovery Institute Showcases Emerging Immersive Neuro-Rehabilitation Technology at Clinical Innovation Open House
  • CCHR Leader's 50-Year Fight for Psychiatric Drug Victims Gains National Momentum
  • Men's Health Month Begins with Record Proclamations, AP News Coverage, & National Momentum for Men's Health
  • Blueshirt Media Launches HIPAA-Compliant AI Call Answering for Addiction Treatment Centers
  • FDA-Cleared AI Neuropsychiatry Platform, Million-Dose Ketamine Manufacturing and Presidential Psychedelic Initiative Drive Growing Momentum for NRXP
  • Accelerating Toward Commercialization as FDA Momentum, AI Neurotherapy & Manufacturing Expansion Drive Multi-Catalyst Growth Story; N A S D A Q: NRXP
  • Tennessee Laws Lead with Psychotropic Drug Testing in Mass Shooting Cases and Comprehensive Reporting: CCHR Urges Nationwide Adoption
  • Medical Experts Highlight the Importance of Second Opinions in Death Investigations
  • USA Med Bed Helping Home Care Patients with Refurbished Hill Rom Hospital Beds
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us